Literature DB >> 17883995

An overview of vaccinations in HIV.

Edgar Turner Overton1.   

Abstract

Prevention is an important aspect of HIV care in the era of highly active antiretroviral therapy. Vaccines provide an excellent opportunity to avert certain infectious diseases for which patients with HIV infection are at increased risk due to immunosuppression. However, the state of immunosuppression reduces the efficacy of vaccines and increases the risk associated with certain vaccines. The study of vaccine responses in patients with HIV infection has greatly advanced the understanding of the underlying immune deficits, particularly with regards to reduced CD4 cell number and function and the level of immune activation associated with chronic viremia. This research has also solidified the safety and utility of vaccines for this population. Continued research of vaccine responses will further our understanding of the immune system and optimize the utilization of routine immunizations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17883995     DOI: 10.1007/s11904-007-0016-7

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.495


  47 in total

1.  Measles and measles immunity in children infected with human immunodeficiency virus.

Authors:  K Krasinski; W Borkowsky
Journal:  JAMA       Date:  1989-05-05       Impact factor: 56.272

2.  Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1993-04-09

3.  Predictors of immunity after hepatitis A vaccination in HIV-infected persons.

Authors:  E T Overton; D Nurutdinova; S Sungkanuparph; W Seyfried; R K Groger; W G Powderly
Journal:  J Viral Hepat       Date:  2007-03       Impact factor: 3.728

4.  Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome.

Authors:  J C Lin; K L Nichol
Journal:  Arch Intern Med       Date:  2001-02-12

5.  Safety and immunogenicity of an inactivated hepatitis A vaccine among HIV-infected subjects.

Authors:  Mark R Wallace; Carolyn J Brandt; Kenneth C Earhart; Barbara J Kuter; Anthony D Grosso; Hassan Lakkis; Sybil A Tasker
Journal:  Clin Infect Dis       Date:  2004-09-24       Impact factor: 9.079

6.  Immune response in HIV-1-infected children with thalassaemia given a primary course of DPT vaccine before acquiring HIV-1 infection.

Authors:  D Chattopadhya; S S Grover; M Sharma; R L Ichhpujani; U K Baveja
Journal:  Ann Trop Paediatr       Date:  2003-12

7.  Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections.

Authors:  Brendan Flannery; Stephanie Schrag; Nancy M Bennett; Ruth Lynfield; Lee H Harrison; Arthur Reingold; Paul R Cieslak; James Hadler; Monica M Farley; Richard R Facklam; Elizabeth R Zell; Cynthia G Whitney
Journal:  JAMA       Date:  2004-05-12       Impact factor: 56.272

8.  Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection.

Authors:  Maria das Graças Sasaki; Roberto Foccacia; Iara J de Messias-Reason
Journal:  Vaccine       Date:  2003-11-07       Impact factor: 3.641

9.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

10.  Unintended smallpox vaccination of HIV-1-infected individuals in the United States military.

Authors:  Sybil A Tasker; Glenn A Schnepf; Matthew Lim; Harold E Caraviello; Adam Armstrong; Mary Bavaro; Brian K Agan; Judith Delmar; Naomi Aronson; Mark R Wallace; John D Grabenstein
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

View more
  1 in total

1.  Simian Immunodeficiency Virus Infection of Rhesus Macaques Results in Delayed Zika Virus Clearance.

Authors:  Carol L Vinton; Samuel J Magaziner; Kimberly A Dowd; Shelly J Robertson; Emerito Amaro-Carambot; Erik P Karmele; Alexandra M Ortiz; Carly E Starke; Joseph C Mudd; Stephen S Whitehead; Sonja M Best; Theodore C Pierson; Heather D Hickman; Jason M Brenchley
Journal:  mBio       Date:  2019-12-03       Impact factor: 7.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.